Mark E. Cooper

Latest

• Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
• Processed foods drive intestinal barrier permeability and microvascular diseases
• Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D